Riskpilot← Back to searchSign inGet full accessCARL ZEISS A/S
A/SActiveCVR 84786217Bregnerødvej 133, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 197941 employees
Revenue 2025
DKK 130,7M
-15% vs 2024
EBITDA margin
6.4%
-12% vs 2024
Equity ratio
32.7%
Financial strength
Net profit 2025
DKK 5,1M
-11% vs 2024
| Revenue | DKK 130,7M | -15% |
| EBITDA | DKK 8,4M | -12% |
| Net profit | DKK 5,1M | -11% |
| Total assets | DKK 57,6M | -12% |
| Equity | DKK 18,9M | -21% |
| Employees | 41 | — |
Legal name
CARL ZEISS A/S
CVR number
84786217
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. februar 1979
Share capital
DKK 2.900.000
Employees
41 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af (i) to medlemmer af bestyrelsen i forening, (ii) et medlem af bestyrelsen i forening med en direktør, eller (iii) to direktører i forening.
Company purpose
Selskabets formål er at drive forretning med handel med optiske instrumenter og brilleoptikprodukter samt anden hermed forbunden virksomhed.
Address
Bregnerødvej 133, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 126.673 | 130.091 | 154.119 | 153.638 | 130.735 |
| Staff expenses | -28.580 | -28.846 | -29.013 | -31.954 | -34.003 |
| EBITDA | 9.091 | 8.492 | 7.360 | 9.496 | 8.362 |
| Depreciation & amort. | -1.319 | -1.226 | -1.782 | -2.279 | -1.853 |
| EBIT | 7.772 | 7.266 | 5.578 | 7.217 | 6.509 |
| Net financials | 2.723 | -1 | -85 | 128 | 38 |
| Profit before tax | 10.495 | 7.265 | 5.493 | 7.345 | 6.547 |
| Tax | 1.637 | 1.607 | 1.129 | 1.608 | 1.455 |
| Net profit | 8.858 | 5.658 | 4.364 | 5.737 | 5.092 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 54.495 | 65.366 | 73.031 | 65.118 | 57.605 |
| Equity | 27.554 | 25.476 | 20.436 | 23.773 | 18.865 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25.399 | 38.170 | 50.736 | 39.755 | 37.811 |
| Total debt | 25.399 | 38.170 | 50.736 | 39.755 | 37.811 |
EBITDA margin
6.4%
This company
15.8%
Market median
-59% vs market
20212025
Equity ratio
32.7%
This company
38.2%
Market median
+14% vs market
20212025
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
20212025
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20212025
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
20212025
Debt / equity
2.05×
This company
0.62×
Market median
-231% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LE Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (5) | ||
BH Management | Management | 1979 – 2003 |
WF Chief Executive Officer | Chief Executive Officer | 2018 – 2024 |
VG Management | Management | 2014 – 2016 |
| Audit | 1979 – 1990 | |
GB Chief Executive Officer | Chief Executive Officer | 2003 – 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Former (13) | ||
| Board of Directors | 1999 – 2012 | |
| Board of Directors | 1979 – 1999 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2012 – 2013 | |
| Board of Directors | 1979 – 2012 | |
| Chairman | 2018 – 2021 | |
| Chairman | 2012 – 2016 | |
| Board of Directors | 2013 – 2016 | |
| Board of Directors | 1979 – 2012 | |
| Chairman | 2018 – 2018 | |
| Board of Directors | 2012 – 2016 | |
| Board of Directors | 1979 – 1999 | |
| Board of Directors | 1979 – 1989 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARL ZEISS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Edlund | Chief Executive Officer | 0 companies |
| Bjarne Hofmann | Management | 0 companies |
| Walther Franz Heger | Chief Executive Officer | 0 companies |
| Vibeke Gram Oxholm | Management | 0 companies |
| Revisionsfirmaet Adrian Johnsen & Ejner Søndberg | Audit | 0 companies |
| Gregers Brock | Chief Executive Officer | 0 companies |
| Tommy Pedersen | Board of Directors | 0 companies |
| Oda Brock | Board of Directors | 0 companies |
| Simon Söhneke Hees | Chairman | 0 companies |
| Herbert Walter Friedrich Kupferschmid | Board of Directors | 0 companies |
| Jørgen Peter Brock | Board of Directors | 0 companies |
| Alexander Ola | Chairman | 0 companies |
| Thomas Spitzenpfeil | Chairman | 0 companies |
| Klaus Leinmüller | Board of Directors | 0 companies |
| Axel Kierkegaard | Board of Directors | 0 companies |
| Alexander Ola | Chairman | 0 companies |
| Herbert Alois Schaden | Board of Directors | 0 companies |
| Michael Gustav Brock | Board of Directors | 0 companies |
| Poul Jarding | Board of Directors | 0 companies |
| Danni Stokbæk | Board of Directors | 0 companies |
| Eva Elisabeth Bromels Callmar | Board of Directors | 0 companies |